| Business Summary |
| The Company provides healthcare solutions that address the evolving needs of patients & societies worldwide with a portfolio that includes innovative medicines, preventive vaccines & diagnostic tools, generic pharmaceuticals & consumer health products. |
| General Information |
Lichtstrasse 35
Basel, 4056
|
|
0.99999983442773
|
| www.novartis.com |
| Industry : Drugs |
| Sector: Health Care |
| Employees: 96717 |
| CEO: Dr. Daniel Vasella, M.D. |
| Short Interest |
| Current Month (Mil) |
6.43 |
| Previous Month (Mil) |
5.01 |
| Short Interest Ratio (Days) |
3.90 |
| Management Effectiveness |
| Return on Equity |
10.40 |
| Return on Assets |
6.10 |
| Return on Investments |
9.00 |
| Profitability |
| Gross Margin |
80.50 |
| EBIT Margin |
22.10 |
| Profit Margin |
18.10 |
Connect with TheStreet